MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line
- PMID: 22643117
- PMCID: PMC3480901
- DOI: 10.1186/1755-8794-5-18
MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line
Abstract
Background: Cancer stem cells (CSCs) are thought to be a source of tumor recurrence due to their stem cell-like properties. MicroRNAs (miRNAs) regulate both normal stem cells and CSCs, and dysregulation of miRNAs has an important role in tumorigenesis. Cluster of differentiation (CD) 133(+) and spheroid formation have been reported to be one of the main features of ovarian CSCs. Therefore, we determined the miRNA expression profile of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line.
Methods: Initially, we confirmed the enrichment of the OVCAR3 CD133 subpopulation by evaluating in vitro anchorage-independent growth. After obtaining a subpopulation of CD133(+) OVCAR3 cells with > 98% purity via cell sorting, miRNA microarray and real-time reverse transcription-polymerase chain reaction (RT-PCR) were performed to evaluate its miRNA profile.
Results: We found 37 differentially expressed miRNAs in the CD133(+) spheroid-forming subpopulation of OVCAR3 cells, 34 of which were significantly up-regulated, including miR-205, miR-146a, miR-200a, miR-200b, and miR-3, and 3 of which were significantly down-regulated, including miR-1202 and miR-1181.
Conclusions: Our results indicate that dysregulation of miRNA may play a role in the stem cell-like properties of ovarian CSCs.
Figures





Similar articles
-
Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3.Oncol Rep. 2011 Jan;25(1):141-6. Oncol Rep. 2011. PMID: 21109969
-
Active glycolytic metabolism in CD133(+) hepatocellular cancer stem cells: regulation by MIR-122.Oncotarget. 2015 Dec 1;6(38):40822-35. doi: 10.18632/oncotarget.5812. Oncotarget. 2015. PMID: 26506419 Free PMC article.
-
Aberrant microRNAs expression in CD133⁺/CD326⁺ human lung adenocarcinoma initiating cells from A549.Mol Cells. 2012 Mar;33(3):277-83. doi: 10.1007/s10059-012-2252-y. Epub 2012 Feb 15. Mol Cells. 2012. PMID: 22349807 Free PMC article.
-
CD133-targeted niche-dependent therapy in cancer: a multipronged approach.Am J Pathol. 2014 May;184(5):1256-62. doi: 10.1016/j.ajpath.2014.01.008. Epub 2014 Feb 28. Am J Pathol. 2014. PMID: 24589338 Free PMC article. Review.
-
MicroRNAs in ovarian carcinomas.Endocr Relat Cancer. 2010 Jan 29;17(1):F77-89. doi: 10.1677/ERC-09-0203. Print 2010 Mar. Endocr Relat Cancer. 2010. PMID: 19903743 Free PMC article. Review.
Cited by
-
MicroRNAs as Key Regulators of Ovarian Cancers.Cell Med. 2019 Sep 6;11:2155179019873849. doi: 10.1177/2155179019873849. eCollection 2019. Cell Med. 2019. PMID: 32634196 Free PMC article. Review.
-
Identification of microRNA profile specific to cancer stem-like cells directly isolated from human larynx cancer specimens.BMC Cancer. 2016 Nov 5;16(1):853. doi: 10.1186/s12885-016-2863-3. BMC Cancer. 2016. PMID: 27816053 Free PMC article.
-
miR-205-5p Mediated Downregulation of PTEN Contributes to Cisplatin Resistance in C13K Human Ovarian Cancer Cells.Front Genet. 2018 Nov 19;9:555. doi: 10.3389/fgene.2018.00555. eCollection 2018. Front Genet. 2018. PMID: 30510566 Free PMC article.
-
MiR-1202 Exerts Neuroprotective Effects on OGD/R Induced Inflammation in HM Cell by Negatively Regulating Rab1a Involved in TLR4/NF-κB Signaling Pathway.Neurochem Res. 2020 May;45(5):1120-1129. doi: 10.1007/s11064-020-02991-7. Epub 2020 Mar 2. Neurochem Res. 2020. PMID: 32124161
-
MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus.Tumour Biol. 2016 Jun;37(6):8007-18. doi: 10.1007/s13277-015-4656-8. Epub 2015 Dec 28. Tumour Biol. 2016. PMID: 26711784
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials